ED
ARRY

Exane Derivatives’s Array Biopharma Inc ARRY Stock Holding History

Exane Derivatives’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,763
Closed -$39.4K – 687
2018
Q4 		$39.4K Buy
+2,763
New +$39.4K 0.01% 352